(Q73472649)
Statements
Mycophenolate mofetil monotherapy: an example of a safe nephrotoxicity/atherogenicity-free immunosuppressive maintenance regimen in a selected group of kidney-transplanted patients (English)
C Keunecke
U Rothenpieler
B Zanker
H Schneeberger
W D Illner
J Theodorakis